GenBio AI Names Ziv Bar-Joseph As Co-Founder & Chief Scientific Officer
28 Feb 2025 //
PR NEWSWIRE
NKGen Doses First Frontotemporal Dementia Patient With Troculeucel
21 Feb 2025 //
GLOBENEWSWIRE
BerGenBio: Q1 2024 Results, Advancing To Next Development Stage
29 May 2024 //
PR NEWSWIRE